Mustang Bio, Inc. (MBIO) Social Stream
MUSTANG BIO INC (MBIO) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering MUSTANG BIO INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-18 | 3 | $13 | $7 | $10.4 | $2.31 | 350.22% |
| 2021-11-15 | 4 | $13 | $7 | $10.4 | $2.31 | 350.22% |
| 2021-12-17 | 5 | $13 | $7 | $9.8 | $2.31 | 324.24% |
| 2022-02-18 | 5 | $11 | $6 | $8.4 | $2.31 | 263.64% |
| 2022-05-16 | 5 | $8 | $6 | $7.25 | $2.31 | 213.85% |
| 2022-05-19 | 4 | $8 | $6 | $7.25 | $2.31 | 213.85% |
| 2022-05-23 | 4 | $8 | $5 | $7 | $2.31 | 203.03% |
| 2022-08-12 | 4 | $8 | $4 | $6.75 | $2.31 | 192.21% |
| 2022-11-15 | 4 | $8 | $4 | $6.25 | $2.31 | 170.56% |
| 2022-11-16 | 4 | $7 | $4 | $5 | $2.31 | 116.45% |
| 2022-12-02 | 5 | $7 | $4 | $5 | $2.31 | 116.45% |
| 2023-03-30 | 4 | $7 | $4 | $5.25 | $2.31 | 127.27% |
| 2023-03-31 | 4 | $104.947 | $59.97 | $71.214 | $2.31 | 2982.86% |
| 2023-05-15 | 4 | $104.947 | $26 | $62.721 | $2.31 | 2615.19% |
| 2023-05-22 | 4 | $59.97 | $7 | $36.235 | $2.31 | 1468.61% |
| 2023-05-23 | 4 | $59.97 | $18 | $40.735 | $2.31 | 1663.42% |
| 2023-06-12 | 4 | $59.97 | $10 | $28.242 | $2.31 | 1122.6% |
| 2023-08-15 | 4 | $25 | $10 | $17.25 | $2.31 | 646.75% |
The Trend in the Analyst Price Target
MBIO's average price target has moved up $11.5 over the prior 12 months.
Over the past 39 weeks, MBIO's average upside potential has been 2,431.16%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-16 | 4 | 7.000 | 4.00 | 5.000 | 0.520 | 861.54% |
| 2023-03-30 | 4 | 7.000 | 4.00 | 5.250 | 5.745 | -8.62% |
| 2023-03-31 | 4 | 104.947 | 59.97 | 71.214 | 0.367 | 19304.36% |
| 2023-03-31 | 4 | 104.947 | 59.97 | 71.214 | 5.499 | 1195.04% |
| 2023-08-15 | 4 | 25.000 | 10.00 | 17.250 | 3.800 | 353.95% |
MBIO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 4 | 0 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 13 months, MBIO's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, MUSTANG BIO INC's upside potential (average analyst target price relative to current price) is greater than 2062.33% of them.
- To contextualize these metrics, consider that out of all US stocks, MUSTANG BIO INC's number of analysts covering the stock is greater than 366.13% of them.
- In the context of all US stocks, MUSTANG BIO INC's average analyst price target is greater than 503.1% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, MUSTANG BIO INC's variance in analysts' estimates is lower than -1495.75% of them.
In the Pharmaceutical Products industry, ACET, KZIA, and VYNE are the three stocks most similar to MUSTANG BIO INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for MBIO? Use POWR Ratings for clearer insight into price direction.